netFormulary
 Report : A-Z CDF items in Formulary 05/04/2020 00:46:32
[Back]
 
Section Status CDF Name
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios
08.01.05 Non Formulary Cancer Drugs Fund Aflibercept Zaltrap
08.01.05 Restricted Use Cancer Drugs Fund Atezolizumab  Tecentriq
08.01.05 Formulary Cancer Drugs Fund Axicabtagene ciloleucel YESCARTA
08.01.01 Formulary Cancer Drugs Fund Bendamustine Levact
08.01.05 Non Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Non Formulary Cancer Drugs Fund Cabozantinib Cometriq
08.01.05 Formulary Cancer Drugs Fund Cemiplimab Libtayo
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux
08.01.03 Non Formulary Cancer Drugs Fund Clofarabine Evoltra
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx
08.01.05 Formulary Cancer Drugs Fund Durvalumab Imfinzi
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy
08.02.04 Formulary Cancer Drugs Fund Ixazomib Ninlaro
08.01.05 Restricted Use Cancer Drugs Fund Lapatinib Tyverb
08.02.04 Formulary Cancer Drugs Fund Lenalidomide  Revlimid
08.01.05 Restricted Use Cancer Drugs Fund Lenvatinib Lenvima
08.01.03 Non Formulary Cancer Drugs Fund Nelarabine Atriance
08.01.05 Formulary Cancer Drugs Fund Niraparib  Zejula
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo
08.02.04 Formulary Cancer Drugs Fund Olaparib Lynparza
08.02.04 Formulary Cancer Drugs Fund Osimertinib Tagrisso
08.01.03 Formulary Cancer Drugs Fund Pemetrexed 
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig
08.03.04.02 Formulary Cancer Drugs Fund Radium-223 dichloride Xofigo
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga
08.03.04.01 Restricted Use Cancer Drugs Fund Ribociclib  Kisqali
08.01.05 Formulary Cancer Drugs Fund Rucaparib Rubraca
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel
08.01.05 Formulary Cancer Drugs Fund Tisagenlecleucel Kymriah
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa
08.01.05 Formulary Cancer Drugs Fund Venetoclax  
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge
Portsmouth and South East Hampshire